Call us + 65 2324-1623

Opening Hours Mon-Sat: 9:00 AM - 5:00 PM

Address 20 Eng Hoon Street, Singapore

MCF IVF IVF Assisted hatching demystified for hopeful parents

Assisted hatching demystified for hopeful parents

Assisted hatching is a laboratory technique used during in vitro fertilization (IVF) in which an embryologist makes a small opening in the embryo’s outer coat, called the zona pellucida. The aim is to help the embryo hatch before it attaches to the uterus, but the procedure does not guarantee implantation or pregnancy. Evidence has not shown a consistent improvement in live-birth rates, and the American Society for Reproductive Medicine (ASRM) does not recommend routine use for every IVF patient. Understanding how the technique works, who might discuss it with a fertility specialist, its potential risks, and the evidence behind it can help hopeful parents make an informed decision.

Assisted hatching and its role in IVF

In a 2022 committee opinion, ASRM defines assisted hatching as the artificial creation of an opening in the zona pellucida surrounding an embryo. In natural development, an embryo gradually breaks free of this protective covering—a process called hatching—before it can implant in the uterine lining. Assisted hatching attempts to alter that step in a laboratory; it does not change the embryo’s chromosomes, improve its quality, or ensure that it will attach.

The technique is an optional add-on to IVF or, in some cases, frozen embryo transfer. It is different from embryo biopsy for genetic testing and from procedures that select or grade embryos. ASRM concluded that evidence does not support routine assisted hatching to improve live-birth rates in patients undergoing IVF. A proposed benefit for selected patients should therefore be weighed against uncertain effectiveness, added cost, and possible risks.

The zona pellucida and embryo hatching

The zona pellucida is a glycoprotein layer that surrounds an egg and early embryo. It helps protect the embryo during early development. As the embryo develops into a blastocyst, it expands and eventually emerges through this layer. Implantation can occur only after the embryo has hatched and interacts with the uterine lining, but successful hatching alone does not guarantee implantation or a live birth.

The main methods of assisted hatching

Embryology laboratories can create an opening in the zona pellucida using different methods. The choice depends on laboratory practice, equipment, and the embryo’s circumstances:

  • Laser-assisted hatching uses a focused laser to thin or open a small area of the zona pellucida. It allows precise work without prolonged chemical exposure.

  • Mechanical hatching uses a fine tool to make an opening. It requires careful handling of the embryo.

  • Chemical hatching uses an acidic solution to thin or dissolve a small part of the zona pellucida. It must be controlled to limit exposure.

These approaches share the same objective, but they are not evidence that the embryo will implant. Patients can ask which method their clinic uses and why it is being proposed in their particular case.

Assisted hatching and patient selection

There is no universally accepted profile of a patient who will benefit from assisted hatching. ASRM’s review found insufficient evidence to recommend it routinely, including for groups sometimes considered for the procedure. A clinic may discuss it after reviewing a patient’s treatment history, embryo characteristics, and available evidence, but a proposed indication should not be presented as a proven way to improve the chance of a baby.

Previous IVF attempts without implantation

Some clinics consider assisted hatching after one or more unsuccessful embryo transfers. However, a failed transfer can have many explanations, and it does not establish that the embryo’s outer coat prevented implantation. ASRM has found that evidence does not demonstrate a consistent live-birth benefit for patients with previous IVF failure. Patients may wish to ask what other factors are being assessed and whether the clinic can explain the expected benefit in absolute, rather than relative, terms.

Embryos with a thicker zona pellucida

A thicker-looking zona pellucida is sometimes cited as a reason to consider assisted hatching. Yet appearance alone does not establish that an embryo cannot hatch naturally, and thickness measurements can vary with imaging and laboratory methods. ASRM notes that evidence has not established that choosing assisted hatching on the basis of zona thickness improves live-birth outcomes.

Age, frozen transfers, and other proposed indications

Advanced maternal age, frozen embryo transfer, and other clinical situations have also been proposed as reasons to use assisted hatching. These are potential discussion points, not guarantees of benefit. The relevant question is whether reliable research shows a meaningful improvement in live birth for patients similar to the person considering treatment. Ask the clinic to identify the evidence supporting its recommendation and whether it applies to the clinic’s specific protocol.

Assisted hatching and the evidence on outcomes

The outcome that matters most to many patients is live birth, not simply a laboratory change or a positive pregnancy test. In its 2022 committee opinion, ASRM reviewed randomized trials and systematic reviews and concluded that routine assisted hatching has not been shown to improve live-birth rates. Studies have varied in patient selection, hatching method, embryo stage, and outcome reporting, making results difficult to generalize.

A 2021 Cochrane review of assisted hatching in assisted reproductive technology found that evidence was uncertain for important outcomes, including live birth. Some analyses have suggested possible changes in clinical pregnancy rates, but that is not the same as demonstrating more babies born. If a clinic quotes a success figure, ask whether it describes implantation, clinical pregnancy, ongoing pregnancy, or live birth—and whether it comes from patients with a similar prognosis.

Why study results can differ

Research results may differ because studies use different patient groups and laboratory techniques. Some include fresh transfers, while others examine frozen embryos; some assess embryos at different developmental stages. Small studies may also be unable to detect uncommon harms or modest differences in live-birth rates. These limitations mean that a promising result in one subgroup should not automatically be treated as proof that the procedure works for everyone.

What patients should ask about success rates

Before agreeing to an add-on, ask the fertility team to distinguish its proposed mechanism from demonstrated clinical benefit. Useful questions include:

  • What outcome does the clinic expect assisted hatching to improve: implantation, clinical pregnancy, or live birth?

  • What evidence supports its use for patients with my age, treatment history, and embryo type?

  • How does the clinic calculate and report its results, and are the figures adjusted for patient characteristics?

  • What is the additional cost, and what are the alternatives if I decline?

Assisted hatching and possible risks

Assisted hatching involves manipulating an embryo, so it carries a possibility of damage, although serious complications are not commonly reported in experienced laboratories. ASRM has also discussed a possible association between assisted hatching and monozygotic twinning, in which one embryo results in identical twins. Multiple pregnancy has health implications for both the pregnant person and babies, so any possible increase in this outcome matters even when the procedure’s overall benefit is uncertain.

Risks depend on the method and the laboratory’s expertise. A small opening that is too large or poorly placed could harm the embryo; chemical methods require controlled exposure. Clinics should explain their safeguards, staff experience, and how they monitor outcomes. A patient-specific risk estimate may not be available, so ask the team what is known and what remains uncertain.

Assisted hatching and a practical decision

For hopeful parents, deciding about an IVF add-on can be emotionally difficult, especially after previous unsuccessful treatment. A useful approach is to ask the clinic to explain the expected benefit, uncertainty, risks, and cost in plain language. If the recommendation is based on a specific feature of the embryo or treatment history, ask how that feature changes the evidence and whether the conclusion is supported by studies measuring live birth.

  1. Clarify the reason: ask why assisted hatching is being suggested in your case, rather than as a routine add-on.

  2. Check the outcome: ask whether the claimed benefit relates to live birth and how large the expected difference is.

  3. Review trade-offs: discuss embryo damage, the possible association with identical twinning, cost, and alternatives.

  4. Take time to decide: ask for written information and consider a second opinion if the explanation is unclear or pressure is involved.

Assisted hatching is a laboratory technique with a plausible biological rationale, but a plausible mechanism is not proof of improved outcomes. ASRM and the Cochrane review both underscore the limits of the evidence. Patients considering IVF can discuss the procedure with a reproductive endocrinologist and embryology team, ask for clinic-specific data, and consult ASRM or Cochrane materials for further reading.

Sources: American Society for Reproductive Medicine, “The role of assisted hatching in in vitro fertilization: a guideline,” Fertility and Sterility, 2022, https://www.asrm.org/practice-guidance/practice-committee-documents/the-role-of-assisted-hatching-in-in-vitro-fertilization-a-guideline-2022/; Lacey et al., “Assisted hatching on assisted conception (IVF and ICSI),” Cochrane Database of Systematic Reviews, 2021, https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001894.pub6/full.